Legend Biotech (LEGN) Earnings Date, Estimates & Call Transcripts $32.50 -1.12 (-3.33%) As of 01/13/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Legend Biotech Latest Earnings SummaryActual EPS (Nov. 12) -$0.34 Beat By $0.22 Consensus EPS (Nov. 12) -$0.56 Legend Biotech released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.34, which beat the consensus estimate of -$0.56 by $0.22. Quarterly revenue rose 66.9% year-over-year to $160.20 million, above the consensus estimate of $143.91 million. With a trailing EPS of -$0.95, Legend Biotech's earnings are expected to grow next year, from ($1.23) to ($0.41) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by Get Legend Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Legend Biotech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLEGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LEGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Legend Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.30-$0.19-$0.25Q2 20252-$0.20$0.24$0.02Q3 20252-$0.18-$0.14-$0.16Q4 20252-$0.05$0.12$0.04FY 20258($0.73)$0.03($0.35) Legend Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024Q3 2024-$0.56-$0.34+$0.22-$0.34$143.91M$160.20M8/9/2024Q2 2024-$0.54-$0.05+$0.49-$0.05$125.25M$186.50M5/13/2024Q1 2024-$0.29-$0.16+$0.13-$0.16$143.24M$93.90M3/11/2024Q4 2023-$0.70-$0.40+$0.30-$0.40$95.63M$76.50M11/20/2023Q3 2023-$0.31-$0.17+$0.14-$0.17$97.25M$96.00M8/15/2023Q2 2023-$0.36-$0.57 -$0.21$0.03$56.64M$73.30M Get the Latest News and Ratings for LEGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. 5/18/2023Q1 2023-$0.56-$0.40+$0.16-$0.46$37.06M$36.34M2/17/2023Q2 2022--$0.41 -$0.41-$0.20-$11.97M Legend Biotech Earnings - Frequently Asked Questions When did Legend Biotech announce their last quarterly earnings? Legend Biotech (NASDAQ:LEGN) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on LEGN's earnings history. Did Legend Biotech beat their earnings estimates last quarter? In the previous quarter, Legend Biotech (NASDAQ:LEGN) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.22. Learn more on analysts' earnings estimate vs. LEGN's actual earnings. How can I listen to Legend Biotech's earnings conference call? The conference call for Legend Biotech's latest earnings report can be listened to online. Listen to Conference Call How can I read Legend Biotech's conference call transcript? The conference call transcript for Legend Biotech's latest earnings report can be read online. Read Transcript How much revenue does Legend Biotech generate each year? Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $520.18 million. How much profit does Legend Biotech generate each year? Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$518.25 million. LEGN has generated -$0.95 earnings per share over the last four quarters. What is Legend Biotech's EPS forecast for next year? Legend Biotech's earnings are expected to grow from ($1.23) per share to ($0.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies TEVA Earnings Results BGNE Earnings Results MRNA Earnings Results GMAB Earnings Results VTRS Earnings Results SMMT Earnings Results RDY Earnings Results SRPT Earnings Results CTLT Earnings Results PCVX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:LEGN) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersGreatest crypto bull market in history?A crypto storm is coming Right now, conditions are in place for a historic move we expect will be the great...Stansberry Research | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredTrump’s 2nd Term Shocker: New AI ComingForget Nvidia. Legendary investor Louis Navellier is recommending this little-known company because it's he...10 Minute Trades | Sponsored Check Out these Stocks Before Trump’s InaugurationAs soon as Trump takes power this coming January 20… He could send these “Trump stocks” higher than anyone ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
